AU4558393A - Ovulation inhibitor for hormonal contraception - Google Patents

Ovulation inhibitor for hormonal contraception

Info

Publication number
AU4558393A
AU4558393A AU45583/93A AU4558393A AU4558393A AU 4558393 A AU4558393 A AU 4558393A AU 45583/93 A AU45583/93 A AU 45583/93A AU 4558393 A AU4558393 A AU 4558393A AU 4558393 A AU4558393 A AU 4558393A
Authority
AU
Australia
Prior art keywords
hormonal contraception
ovulation inhibitor
ovulation
inhibitor
contraception
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45583/93A
Inventor
Marika Ehrlich
Herbert Kuhl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4558393A publication Critical patent/AU4558393A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU45583/93A 1992-07-24 1993-07-26 Ovulation inhibitor for hormonal contraception Abandoned AU4558393A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4224534A DE4224534A1 (en) 1992-07-24 1992-07-24 Anti-ovulation agent for hormonal contraception
DE4224534 1992-07-24
PCT/DE1993/000656 WO1994002103A2 (en) 1992-07-24 1993-07-26 Ovulation inhibitor for hormonal contraception

Publications (1)

Publication Number Publication Date
AU4558393A true AU4558393A (en) 1994-02-14

Family

ID=6464040

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45583/93A Abandoned AU4558393A (en) 1992-07-24 1993-07-26 Ovulation inhibitor for hormonal contraception

Country Status (6)

Country Link
EP (1) EP0651644A1 (en)
JP (1) JPH07509454A (en)
AU (1) AU4558393A (en)
CA (1) CA2140011A1 (en)
DE (1) DE4224534A1 (en)
WO (1) WO1994002103A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429374C1 (en) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmaceutical preparations for contraception / hormone substitution with biogenic estrogen component
DE19504227C2 (en) * 1995-02-09 1999-04-29 Klaus Dr Med Umbreit Anti-ovulation agent for hormonal contraception
DE19525017A1 (en) * 1995-06-28 1997-01-02 Schering Ag Pharmaceutical combination preparation, kit and method for hormonal contraception
DE19540253C2 (en) * 1995-10-28 1998-06-04 Jenapharm Gmbh Multi-phase preparation for contraception based on natural estrogens
AU3888697A (en) * 1996-07-26 1998-02-20 American Home Products Corporation Progestin/estrogen oral contraceptive
ES2399480T3 (en) 1997-11-10 2013-04-01 Memorial Sloan-Kettering Cancer Center Production process of arsenic trioxide formulations
DE10100911A1 (en) 2001-01-11 2002-08-01 Schering Ag Process for hormone replacement therapy and its dosage form
ATE254465T1 (en) * 2001-05-23 2003-12-15 Pantarhei Bioscience Bv PREPARATIONS FOR HORMONAL CONTRACEPTION
SI1453521T1 (en) 2001-12-05 2013-11-29 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
RU2403046C2 (en) * 2003-07-16 2010-11-10 Тева Вимен'С Хелс, Инк. Method of hormonal treatment with application of contraceptive regimens with continuous introduction of estrogen
DE102004019743B4 (en) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Multiphase preparation for contraception based on natural estrogen
DE102004026670A1 (en) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonal contraceptive containing a combination of ethinylestradiol and chlormadinone acetate
DE102004026671A1 (en) 2004-05-28 2005-12-15 Grünenthal GmbH Dosage form for hormonal contraception
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (en) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Application of estradiol valerate or 17ß-estradiol in combination with dienogest for oral therapy to maintain and/or increase the female libido

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104385C1 (en) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
JPH07509454A (en) 1995-10-19
WO1994002103A2 (en) 1994-02-03
WO1994002103A3 (en) 1994-05-11
DE4224534A1 (en) 1994-01-27
EP0651644A1 (en) 1995-05-10
CA2140011A1 (en) 1994-01-25

Similar Documents

Publication Publication Date Title
AU4651793A (en) Uterine retractor
AU3802493A (en) Surgical endoclip
AU3148095A (en) Uterine manipulator
AU4995993A (en) Surgical retractor
AU3688393A (en) Surgical fastener
AU7572294A (en) Surgical clip applier
ZA947572B (en) Contraceptive compositions
AU4944093A (en) Osteosynthesis aid
AU4558393A (en) Ovulation inhibitor for hormonal contraception
AU7835994A (en) Device introducing pharmaceuticals into uterine cervix
AU3282489A (en) Intra-uterine pessary
AU7137196A (en) Contraceptive device
AU7749394A (en) Methods for inhibiting uterine fibrosis
AU7001496A (en) Anti-inflammatory agent
AU6836896A (en) Fertility agent
AU696242B2 (en) Packaging case for condoms
AU4708993A (en) Antiprogestogen containing contraceptives
AU2770195A (en) Release mechanism for cans
AU4971193A (en) Discharge device
AU4894196A (en) Intrauterine contraceptive device
AU2812195A (en) Inhibitor
AU697487B2 (en) Therapeutic agent for ischemic diseases
AU5118493A (en) Aromatase inhibitor
AU5402290A (en) Applicator for male contraceptive
AU3454793A (en) Contraceptive protection means